PARIET

This brand name is authorized in Australia, Austria, Brazil, Canada, Cyprus, Finland, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Lithuania, Malta, Mexico, Netherlands, Singapore, South Africa, Spain, Turkey, UK.

Active ingredients

The drug PARIET contains one active pharmaceutical ingredient (API):

1	Rabeprazole UNII 3L36P16U4R - RABEPRAZOLE SODIUM
	Rabeprazole belongs to the class of anti-secretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or H2 histamine antagonist properties, but suppress gastric acid secretion by the specific inhibition of the H+/K+ -ATPase enzyme (the acid or proton pump).
	Read more about Rabeprazole

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PARIET Gastro-resistant tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A02BC04	Rabeprazole	A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02B DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) → A02BC Proton pump inhibitors
Discover more medicines within A02BC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11670F, 12286P, 8507R, 8508T, 8509W
BR	Câmara de Regulação do Mercado de Medicamentos	514503301118214, 514503304117219, 514503305113217, 514503306111218, 514512110026303, 514516020032203
CA	Health Products and Food Branch	02243796, 02243797
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00176578, 00176584, 00176590, 00176621, 00176638, 00176644, 03743339, 03743345, 13981904, 16206270
ES	Centro de información online de medicamentos de la AEMPS	034216186-M, 039351010, 3400935514790, 355147-9, 355147-9IP, 62461, 62462
FI	Lääkealan turvallisuus- ja kehittämiskeskus	065083, 108780, 378482, 514346, 551879, 557015, 568238
FR	Base de données publique des médicaments	62909137, 66035518
GB	Medicines & Healthcare Products Regulatory Agency	139447, 139449, 175884, 196973, 198588, 20088, 20094
HK	Department of Health Drug Office	44935, 44936
IE	Health Products Regulatory Authority	38811, 38825, 38868, 38920
IT	Agenzia del Farmaco	034216022, 034216186
JP	医薬品医療機器総合機構	2329028F1023, 2329028F2020, 2329028F3026
LT	Valstybinė vaistų kontrolės tarnyba	1021251, 1021252, 1021253, 1021254
MT	Medicines Authority	MA018/01901, MA018/01902, PI521/07404A, PI770/17301A, PI908/07701A, PI908/07702A
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	505M98
NL	Z-Index G-Standaard, PRK	54860, 54879
SG	Health Sciences Authority	11232P, 11233P, 15531P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699593045295
ZA	Health Products Regulatory Authority	32/11.4.3/0614, 33/11.4.3/0206